MDT - AtriCure defended at UBS despite Medtronic's rival product
2023-11-29 08:53:57 ET
More on AtriCure
- AtriCure: Appeal Lures For This Cure
- AtriCure, Inc. (ATRC) Q3 2023 Earnings Call Transcript
- Needham says Medtronic could create overhang on AtriCure shares
- Seeking Alpha’s Quant Rating on AtriCure
- Historical earnings data for AtriCure
For further details see:
AtriCure defended at UBS despite Medtronic’s rival product